Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Takeda's Rozerem Substance Abuse/Toxicity Claims Draw FDA Rebuke

Mar 26 2010

• By PharmAsia News

Related Content

Sleep Agents Update Warnings As FDA Seeks Further Study Of “Complex” AEs

Mar 19 2007

Somaxon's Silenor Gains An FDA Approval, But Can The Pharma Afford A Launch?

Mar 18 2010

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window